A $5 million gift from philanthropists Judith and Stewart Colton will establish a Colton Center for Autoimmunity within the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai. This move expands research focused on earlier detection, precision treatment, disease prevention, and improved outcomes for people living with autoimmune diseases. The new Colton Center for Autoimmunity at Mount Sinai will become part of the Colton Consortium for Autoimmunity, an international research collaborative that brings together leading institutions to accelerate scientific discovery through data sharing, multidisciplinary collaboration across institutions, and rapid translation of research findings into new diagnostics, biomarkers, and therapies.

People’s Medical Publishing House organized a symposium on medical journal development. The event also marked the first meeting of Global Health Journal’s newly constituted 4th editorial board. In the event, prominent academics and industry experts discussed new methods to make Chinese medical research more accessible and reputable around the world.

Findings showed that people’s attachment was less often about meat itself – and more about links to personal experiences and cultural traditions.

Heart failure affects more than 60 million people worldwide and remains one of the leading causes of hospitalization and premature mortality. A new expert statement published in the European Heart Journal shifts the focus from treating advanced disease to preventing it before symptoms appear.

The statement—the first comprehensive document devoted exclusively to heart failure prevention—summarizes current evidence on modifiable risk factors, early identification of high-risk individuals, and strategies that can reduce disease burden throughout life.

Experts from Wroclaw Medical University contributed to the statement, emphasizing the central role of primary care, cardiovascular risk assessment, and public health education. According to the authors, preventing hypertension, diabetes, obesity, and chronic kidney disease through lifestyle interventions and timely treatment may substantially reduce future heart failure cases.

The publication argues that the greatest opportunity to prevent heart failure occurs long before patients develop symptoms, highlighting prevention as one of the most effective strategies for addressing the growing global burden of cardiovascular disease.